{"id":33016,"date":"2022-04-27T09:00:00","date_gmt":"2022-04-27T07:00:00","guid":{"rendered":"https:\/\/www.ipsen.com\/press-releases\/ipsen-realise-une-solide-performance-de-ses-ventes-au-premier-trimestre-2022\/"},"modified":"2024-07-23T09:16:37","modified_gmt":"2024-07-23T07:16:37","slug":"ipsen-realise-une-solide-performance-de-ses-ventes-au-premier-trimestre-2022","status":"publish","type":"press_release","link":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-realise-une-solide-performance-de-ses-ventes-au-premier-trimestre-2022\/","title":{"rendered":"Ipsen r\u00e9alise une solide performance de ses ventes au premier trimestre 2022"},"content":{"rendered":"

Ipsen r\u00e9alise une solide performance de ses ventes <\/b>au premier trimestre 2022<\/b><\/p>\n

Paris (France), le 27 avril 2022 <\/b>\u2013 Ipsen (Euronext : IPN ; ADR : IPSEY), groupe biopharmaceutique mondial de sp\u00e9cialit\u00e9, publie aujourd\u2019hui son chiffre d\u2019affaires pour le premier trimestre 2022.<\/p>\n

Faits marquants<\/b><\/p>\n